All News
All series
All All News
Advertisement
Advertisement
Xalkori improves survival in patients with ALK-positive lymphoma.
Goals and milestone recognitions may help children with cancer get through treatment a little easier.
Clinical trial results suggests that pathologic complete response after HER2-positive therapy equates to great survival.
Small Yet Significant Steps in Treating Triple-Negative Breast Cancer
Aromatase inhibitors may help prevent breast cancer.
When it comes to relieving joint pain from aromatase inhibitors, motion is lotion.
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
3
KTX-1001 Elicits Responses in Some With Multiple Myeloma
4
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
5